CERE
Cerevel Therapeutics Holdings, Inc.
Director N Anthony Coles sold $573K of Cerevel Therapeutics Holdings, Inc.
Sold$573,455
$25.13Price
22,824Shares
−89%Stake
What CERE did after the filing
- The stock from Thu, Nov 16 close, $24.65
- +71.2%
- S&P 500, same days
- +5.4%
Measured over 30 trading days, to the Jan 2 close.
Traded Tue, Nov 14. Filed Thu, Nov 16, 11:15 AM ET, during the session. Returns use the Nov 16 close and the Jan 2 close. Not investment advice.